PerkinElmer
check quantity

IVIS Lumina XRMS In Vivo Imaging System

Industry leading Fluorescence, Bioluminescence and X-Ray Imaging - All-In-One benchtop instrument! The IVIS® Lumina XRMS (x-ray multi-species optical imaging system) adds to the versatility of the IVIS Lumina XR by offering the flexibility to image large animals up to 500 grams with precise optical and X-Ray overlay.

Part Number CLS136340
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

For research use only. Not for use in diagnostic procedures.

Overview

IVIS Lumina XRMS III 将数年积累的先进光学成像技术整合于一体,打造出一个易于操作且性能非凡的多模式活体光学成像系统。通过使用 Lumina XRMS III,研究者可实现对小鼠、大鼠及其它模式动物的高灵敏生物发光、多光谱荧光、放射性核素及低剂量X光的联合成像。

依托多达 26 个滤光片的配置,使用者可对从绿光到近红外光的几十种荧光探针进行成像。配备的新型激发光源,使光源激发效能在整个成像光谱范围内始终处于高水平,有效增强了系统对深层荧光信号的探测能力。

Lumina XRMS III提供了灵活便捷的X光成像方式,使用者可以通过调节X光转换屏的位置,实现对小鼠、大鼠及体重为 500-600克的其它模式动物进行X光成像。软件可将光学及X光成像结果自动准确地对位融合在一起,并且 Lumina XRMS 是目前市场上唯一能够在所有成像视野实现光学信号与X光信号叠加融合的成像系统。

 

主要性能:

  • 可见光及X光多模式成像
  • 能够成像小鼠及大鼠等多种模式动物
  • 高分辨率、低辐射X光成像
  • 高灵敏度生物发光成像
  • 基于多光谱分离的高灵敏度荧光成像
  • 成像范围覆盖整个可见光及近红外光波段

Specifications

Height 104.0 cm
Imaging Modality Optical Imaging
Optical Imaging Classification Bioluminescence imaging, Fluorescence Imaging
Portable No
Product Brand Name IVIS
Width 48.0 cm
Resources, Events & More
  • All

Application Note

Cerenkov Imaging of Radioisotopes in IVIS systems

Cerenkov Emission from radioisotopes in tissue,Optical imaging detects photons in the visible range of the electromagnetic,spectrum. PET and SPECT imaging instruments are sensitive to photons in the much,higher energy range of x-rays and gamma rays. While the PET and SPECT probes,which can generate Cerenkov light in tissue will continue to produce the relevant,gamma- and x-rays, visible photons will be produced from the Cerenkov emission,which the IVIS® will detect.,In beta decay emitters such as PET probes and isotopes such as 90Y, 177Lu, 131I and 32P,the beta particle will travel in the tissue until it either annihilates with an electron or,loses momentum due to viscous electromagnetic forces.,It is possible that the beta (electron or positron),is relativistic, traveling faster than the speed,of light in the tissue. While it is impossible,to travel than the speed of light in a vacuum,(c), the speed of light in tissue is v = c / n,where n is the tissue index of refraction and,n = 1. Cerenkov photons will be generated,by a relativistic charged particle in a dielectric medium such as tissue.

PDF 2 MB
Stem Cell Research and Regenerative Medicine

With the potential to treat a wide range of disease, from organ damage to congenital defects, stem cell research and tissue engineering form the underlying basis of regenerative medicine. Significant advances in the science of skin regeneration, for example, have now made it possible to develop and grow artificial skin grafts in a lab for treatment of burn victims. Other therapeutic applications include the use of stem cells to treat and repair central nervous system diseases such as ischemia and cerebral palsy, cardiovascular diseases, as well as autoimmune diseases including type I diabetes.

PDF 1 MB

Featured Publication Note

Product Note

IVIS Lumina XRMS Series III Product Note

IVIS Lumina XR Series III Integrating Gold Standard Bioluminescence, Fluorescence and X-Ray In Vivo Technologies. The IVIS Lumina XR Series III from PerkinElmer provides an expandable, sensitive imaging system that is easy to use for fluorescent, bioluminescent, radioistopic and X-Ray imaging in vivo. As the leading optical imaging platform for in vivo analysis, IVIS systems include a range of practical accessories developed through experience in research laboratories worldwide.

PDF 2 MB

Software Downloads

Technical Note

Adaptive Fluorescence Background Subtraction

Adaptive Fluorescence Background Subtraction Pre-clinical in vivo imaging technical note for IVIS Imaging Systems. Instrument background occurs when excitation light leaks through the emission filter. This occurs more frequently when the excitation and emission filters are narrowly separated. The ring you see is a result of non specific light reflecting off of the stage at an incident angle and passing through the filter causing what appears as leakage around the edges.

PDF 1 MB
AutoExposure

Auto-exposure technical note for IVIS pre-clinical imaging systems

PDF 1 MB
Background ROI

Subtracting Background ROI from a Sequence

PDF 1 MB
Determine Saturation

Determine Saturation for IVIS imaging systems - technical note

PDF 1 MB
Drawing ROIs

Technical notes for Drawing ROIs for IVIS in vivo imaging systems. The circle, square, free draw, or grid (for well plates) can be used to draw your ROIs. ROI selections,are user-specific and are dependent on the model being analyzed. It is irrelevant which shape that is used for a particular ROI.

PDF 669 KB
High Resolution Images

Acquisition of High Resolution Images. This quick reference guide is for those researchers who wish to perform analysis that requires high resolution including in vitro studies when one may want to discern aspects about cell layers, ex vivo tissue imaging, or imaging of tissue slices. You will not need this resolution in most in vivo studies.

PDF 1 MB
Image Overlay 2D

Not only is it possible to load multiple images as a group, for example multiple days of a longitudinal study, but it is also possible to load multiple images and Overlay them i.e. bioluminescent tumor with fluorescent targeted drug acquired in two separate images.

PDF 472 KB
Loading Groups of Images

For many studies, it may be desirable to open a group of images together, for example, analyzing multiple days of longitudinal study side by side using the same scale.

PDF 751 KB
Subject ROI

Subject ROI using IVIS imaging systems

PDF 2 MB
Working with Image Math

Working with Image Math. Image Math is a rudimentary but effective method for Spectrum and Lumina users to subtract background from images without performing Spectral Unmixing.

PDF 911 KB

Video Article

White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick and efficient drug screening and evaluation. Read this White Paper to learn how preclinical in vivo imaging helps to ensure that smart choices are made by providing Go/No-Go decisions and de-risking drug candidates early on, significantly reducing time to the clinic and lowering costs all while maximizing biological understanding.

PDF 748 KB